Member Info for Dibs61

Have a feeling we have another attempt on dropping the SP coming. Possibly the last one before news, the opportunity goes with low volume. It’s been nearly two months now since the big July announcement.

Thanks for posting, interesting. Two immediate observations. The first is their drug is aimed specifically towards with patients with severe Covid19 (ICU) whilst SNG001 is aimed toward patients diagnosed prior to hospitalisation and those in hospital but not on a ventilator (mild/developing to moderate). Also if you call Synairgens Phase 2 small this is VERY small with just 30 patients. My initial conclusion - therefore not a competitor to SNG001.

Parsley - how destructive were people who claimed this would be £2.50 when it was 30p? Or even 10p? A 2500% increase. How ‘destructive’ were they Parsley? There’s a smart arse on every board who think they know better than everybody else.

Should be broken soon looking very strong today

HSD - if feels like you keep firing arrows but missing the target this morning!

strictly - precisely but you get the odd one who just wants to read something into it that’s not there. Quite apart from the fact they’re probably up to there eyes busy atm!,

HSD - it won’t be any good to anyone if it were ready by mid next year. I think you’ll find it’ll be ready before then. The question will be the quantity but RM has already talked in terms of hundreds of thousands to millions of doses. Don’t forget they started the process back in April in anticipation.

I have responded and submitted my comments to the DHSC Consultation

Johnsam - thanks for sharing excellent stuff. And note the following from the UK government summary on vaccines and treatments:

‘The consultation covers:

authorising temporary supply of an unlicensed product‘

Injected Interferon is utterly irrelevant in this scenario. It’s for use in other parts of the body and why oh why bring it up?

SNG001 has an excellent safety profile.

A key excerpt from Articke:

Something else has gone largely unnoticed. The two most effective treatments for Covid-19, which have brought down death rates and eased the damage to patients, are products of UK scientists. It was British researchers who discovered that the most effective drug treatment was dexamethasone, a widely used steroid, which is low cost and widely available.

“Moreover, scientists at the University of Southampton and their commercial spinout Synairgen found that their inhaled antiviral drug SNG001 significantly reduced the odds of patients hospitalised with Covid-19 coming down with respiratory disease. The first patient studies showed a remarkable 79 per cent effectiveness. “

Wakey wakey market its coming......

https://uk.reuters.com/article/us-health-coronavirus-remdesivir-exclusi/exclusive-u-s-hospitals-turn-down-remdesivir-limit-use-to-sickest-covid-19-patients-idUKKBN2622UM

kevkan - no the trading pattern has changed. The bid is slowly being raised. When our seller was active it was slowly dropping. Only small sells are being shown. The larger buys are background and being delayed. IMO the seller has finished and the buyer has come back in.

Judging by this afternoon’s SP action I wonder if our US buyers are active again....

Graking - on the assumption that immunosenescence has not been mentioned in the SNG RNS I would ask you the question has it been mentioned in any other companies RNS announcements re Covid 19 treatments? Is this just related to Synairgen? I doubt it. I think we need to start from this standpoint.

Can’t be bothered to trade. Can see how you could sell early and buy (more) back cheaper later but it can often get tricky to buy in quantity here. Happy to sit tight and wait for the BIG gains.

A pattern last few days someone sells aggressively on the bell - no other purpose surely than to drive the price down. That sets the trend for the day and makes it easier to buy.

Indeed. It is tempting to think that this price action is leading to a placing. But I think that is now the crucial question- funding. How is the next stage going to be funded? And probably that uncertainty which is causing a wobbly SP.

The question should shortly be answered but whatever the source of funding may be that will remove the uncertainty and then it is likely to be a scramble to accumulate and maybe quite difficult to buy in quantity. Which is why this is such a fantastic opportunity right now to enter or add if you are able. Unfortunately I’m fully loaded now!

But I am not selling a single share here.

Added a few more this morning @ 1.88

Ah thanks Greg, that was going to be my question, whether the patent can be copied whilst the patent application is being processed. That is excellent news then.